Director, Electrophysiology Laboratory
Assistant Clinical Professor of Medicine

E-Mail

Penn Presbyterian Medical Center
Philadelphia Heart Institute - 4th Floor
39th & Market Streets
Philadelphia, PA 19104

Appointments
Contact: Andrea Monahan (215) 662-9007

Clinical Specialty:

• Cardiovascular Medicine
• Clinical Electrophysiology

Practice Location:

• Penn Presbyterian Medical Center, PHI
• Penn Cardiology, Route 70, Cherry Hill, NJ

Education:

• MD: Upstate Medical Center SUNY Health Science Center
• Residency: Medical College of Pennsylvania
• Fellowship: Cooper Hospital, University Medical Center, Camden, NJ
• Postdoctoral Fellowship: Cooper Hospital, University Medical Center, Camden, NJ

Research Interest:

• Implantable Cardioverter Defibrillators
• Cardiac Resynchronization Therapy
• Gender Differences in Arrhythmias

Selected Publications:

1. Matecon IJ, Haft JI, Rubenstein DG, Russo AM. Radiofrequency ablation cures Wolff-Parkinson-White Syndrome. Contemp Int Med 1992;99-105.
2. Russo AM, O'Connor WH, Waxman HL. Incidence of atypical presentations and echocardiographic findings in patients with cardiac tamponade occurring early and late after cardiac surgery. CHEST 1993;104:71-78.
3. Russo AM, Beauregard LM, Waxman HL. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease. Am J Cardiol 1993;72:1395-1399.
4. Beauregard LM, Bernard PW, Russo AM, Waxman HL. Perceived and actual risks of driving in patients with arrhythmia control devices. Arch Intern Med 1995;155:609-613.
5. Beauregard LM, Russo AM, Heim J, Snyder H, Waxman HL. Twiddler's syndrome complicating automatic defibrillator function. PACE 1995;18(4):735-738.
6. Marchlinski FE, Zado ES, Callans DJ, Patel VV, Ashar MS, Hsia HH, Russo AM. Hybrid therapy for ventricular arrhythmia management. Cardiology Clinics 2000;18(2):391.
7. Marchlinski FE, Hsia H, Russo AM, Callans D, Verdino R, Kocovic D, Pavri B, Zado E, Patel V, Ashar M, Toluie K, Dixit S, Rho R, Dias D. Antiarrhythmic drugs during implantable cardioverter defibrillator followup: Drug selection and potential adverse interactions. In: Santini M (ed), Progress in Clinical Pacing 2000, CEPI – AIM Group, Rome, Italy, chapter 29, pp 177-182.
8. Russo AM, Marchlinski FE: Long-term ICD follow-up in therapy with implantable cardioverter-defibrillators – A practical guide. Editor Antonio Pacifico. Kluwer Academic Publisher, The Netherlands (in press).
9. Russo AM, Verdino R, Schorr C, Nicholas M, Dias D, Hsia H, Callan D, Marchlinski F. Occurrence of Implantable Defibrillator Events In Patients With Syncope and a Nonischemic Dilated Cardiomyopathy. AJC 2001;88:1444-1446.
10. Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K, Buxton AE and the MUSTT Investigators. Influence of Gender on Arrhythmia Characteristics in the Multicenter UnSustained Tachycardia Trial.  J Cardiovasc Electrophysiol 2004 Sep;15:993-998.
11. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, Verdino RJ, Nayak HM, Callans DJ, Patel V, Marchlinski FE.  Defibrillation Threshold Testing: Is It Really Necessary at the Time of Implantable Cardioverter-Defibrillator Insertion? Heart Rhythm 2005;May;2:456-461.
12. Russo AM, Hafley GE, Lee KL, Stamato NJ, Lehmann MH, Page RL, Kus T, Buxton AE.  Racial Differences in the Multicenter UnSustained Tachycardia Trial (MUSTT): A Comparison of Whites Versus Blacks.  Circulation 2003;108:67-72.